Edition:
United States

Corbion NV (CORB.AS)

CORB.AS on Amsterdam Stock Exchange

26.80EUR
11:35am EST
Change (% chg)

€0.10 (+0.37%)
Prev Close
€26.70
Open
€26.75
Day's High
€26.83
Day's Low
€26.60
Volume
161,555
Avg. Vol
120,505
52-wk High
€30.47
52-wk Low
€23.41

Latest Key Developments (Source: Significant Developments)

Corbion provides financial guidance for 2018-2021 period
Thursday, 9 Nov 2017 01:00am EST 

Nov 9 (Reuters) - CORBION NV ::FOR 2018-2021 AIMS TO PAY OUT ANNUALLY A STABLE TO GRADUALLY INCREASING ABSOLUTE DIVIDEND AMOUNT PER SHARE‍​.INNOVATION PLATFORMS EBITDA MAXIMUM LOSS IS NOT EXPECTED TO EXCEED € -35 MILLION PER ANNUM FOR THE YEARS 2018 AND 2019 ‍​.2018-2021 GUIDANCE: INGREDIENT SOLUTIONS: NET SALES GROWTH OF 2-4% PER ANNUM‍​.2018-2021 GUIDANCE IN INGREDIENT SOLUTIONS: MAINTAINING EBITDA MARGIN >19% AND ROCE >20% PER ANNUM DURING PERIOD.2018-2021 GUIDANCE IN INNOVATION PLATFORMS: NET SALES GROWTH (INCL. PROPORTIONATELY CONSOLIDATED JVS) 10-30% PER ANNUM.2018-2021 GUIDANCE IN INNOVATION PLATFORMS: EBITDA (INCLUDING PROPORTIONATELY CONSOLIDATED JVS) APPROACHING BREAK-EVEN IN 2021.2018-2021 GUIDANCE IN INNOVATION PLATFORMS: EBITDA MAX. LOSS NOT EXPECTED TO EXCEED €-35 MILLION PER ANNUM FOR YRS 2018 AND 2019.2018-2021 GUIDANCE IN INNOVATION PLATFORMS: RECURRING CAPEX (INCLUDING PROPORTIONATE SHARE IN JV CAPEX) OF €20-30 MILLION PER ANNUM.  Full Article

Corbion 9M sales down 0.7% at 680.5 million euros
Friday, 27 Oct 2017 01:00am EDT 

Oct 27 (Reuters) - CORBION NV : :SALES OF EUR 680.5 MILLION IN FIRST 9 MNTHS OF 2017, DECREASE OF 0.7% COMPARED TO SAME PERIOD IN 2016​.‍ORGANIC SALES GROWTH IN Q3 WAS FLAT​.9MONTH OPERATING RESULT EUR ‍​102.5 MILLION VERSUS EUR 93.1 MILLION YEAR AGO.OUTLOOK FOR 2017 IS UNCHANGED.‍EBITDA EXCLUDING ONE-OFF ITEMS IN FIRST 9 MTHS DECREASED BY 3.6% TO EUR 129.9 MILLION​.  Full Article

Corbion acquires Terravia
Friday, 29 Sep 2017 01:00am EDT 

Sept 29 (Reuters) - CORBION NV ::REG-INNOVATIVE MICROALGAE SPECIALIST TERRAVIA ACQUIRED BY CORBION.ANNOUNCED THE COMPLETION OF THE ACQUISITION OF SUBSTANTIALLY ALL ASSETS OF TERRAVIA HOLDINGS (TERRAVIA).CORBION HAS PAID A CASH PURCHASE PRICE OF APPROXIMATELY US$ 20 MILLION..FINANCIAL GUIDANCE: PRO-FORMA(1) EBITDA EXPECTED TO BE POSITIVE FROM 2020 ONWARDS.‍ACQUISITION EXPECTED TO ENHANCE CORBION'S LONG TERM PRO-FORMA SALES GROWTH BY 100BPS P.A​.EBITDA IMPACT: NEGATIVE IN 2017 AND COMING YEARS DUE TO HIGH RESEARCH AND DEVELOPMENT INTENSITY.EBITDA IMPACT RANGE FOR 2017: US$ -7 MILLION TO -12 MILLION.  Full Article

Corbion H1 operating result YTD increases by 10.8%
Wednesday, 9 Aug 2017 01:00am EDT 

Aug 9 (Reuters) - CORBION NV ::REG-CORBION FIRST HALF 2017 RESULTS.H1 NET SALES ORGANIC GROWTH YTD WAS -0.9%; VOLUME GROWTH WAS -1.6%.H1 OPERATING RESULT YTD EUR 73.1 MILLION VERSUS EUR 63.4 MILLION YEAR AGO.H1 EBITDA BEFORE ONE-OFF ITEMS YTD WAS EUR 88.3 MILLION, AN ORGANIC DECREASE OF 6.2%.H1 ONE-OFF ITEMS AT EBITDA LEVEL OF EUR 6.0 MILLION, MOSTLY IN CONNECTION WITH NEWLY FOUNDED TOTAL CORBION PLA JOINT VENTURE.H1 OPERATING RESULT YTD WAS EUR 73.1 MILLION, AN ORGANIC INCREASE OF 10.8%.OUR OUTLOOK FOR 2017 IS UNCHANGED.  Full Article

Corbion signs agreement to bid for substantially all of the assets of Terravia
Wednesday, 2 Aug 2017 12:43am EDT 

Aug 2 (Reuters) - Corbion NV - :REG - Corbion signs agreement to bid for substantially all of the assets of innovative microalgae specialist TerraVia.Corbion offered a cash purchase price of approximately $20 million.Corbion NV - execution of stock and asset purchase agreement subject to a sale process to be conducted under section 363 of U.S. Bankruptcy code.As TerraVia's operations are currently loss making, expects financial commitments to be substantially in excess of purchase price..TerraVia announced it filed a voluntary petition under chapter 11 of U.S. Bankruptcy code on 2 August, 2017.  Full Article

Corbion to list 2,027,017 new shares following conversion of convertible bonds - Euronext
Monday, 26 Jun 2017 03:52am EDT 

June 26 (Reuters) - Euronext::CORBION NV <<>> TO LIST 2,027,017 NEW ORDINARY SHARES ON EURONEXT AMSTERDAM AS OF JUNE 27 FOLLOWING CONVERSION OF NON LISTED CONVERTIBLE BONDS .  Full Article

Corbion reappoints Chairman of Supervisory Board; extends CEO's contract
Monday, 15 May 2017 11:52am EDT 

May 15 (Reuters) - CORBION NV ::REG-CORBION GENERAL SHAREHOLDERS MEETING APPROVES BOARD REAPPOINTMENTS AND DIVIDEND.ANNOUNCES THAT CONTRACT OF ASSIGNMENT OF TJERK DE RUITER, CEO, WILL BE EXTENDED FOR AN ADDITIONAL PERIOD OF 2 YEARS.CORBION SHAREHOLDERS ALSO REAPPOINTED MR. VRIJSEN AS CHAIRMAN OF SUPERVISORY BOARD.  Full Article

Corbion Q1 2017 sales up 0.7 pct at 229.9 million euros
Tuesday, 25 Apr 2017 01:00am EDT 

April 25 (Reuters) - Corbion NV ::Sales of 229.9 million euros ($249.76 million) in Q1 of 2017, an increase of 0.7 pct.Organic sales growth was -2.3 pct, mostly due to a volume decrease in Food.Q1 EBITDA excluding one-off items increased by 9.4 pct to 47.8 million euros.For biobased ingredients expect quarterly sales growth to improve as we move further into 2017.As losses in Bakery will dampen growth, expect 2017 net sales growth in Biobased Ingredients to end up below multi-year guidance bandwidth of 2-4 pct.Continue to expect our total Corbion EBITDA excluding one-off items for 2017 to be slightly below that of 2016.  Full Article

Corbion to execute 25 million euro share buyback program in 2017
Tuesday, 18 Apr 2017 01:01am EDT 

April 18 (Reuters) - Corbion NV ::Will execute a share buyback program of 25 million euros ($26.61 million) in 2017; share buyback program will be executed as from April 18.  Full Article

Corbion FY EBITDA excluding one-off items grew up 13.2 pct at 170.1 million euros
Monday, 6 Mar 2017 01:00am EST 

Corbion Nv : FY net sales organic growth was -1.2 pct; volume growth was -1.2 pct . FY EBITDA 170.1 million euros ($180.32 million)versus 150.3 million euros year ago . To distribute a regular dividend of 0.56 euros per share, an additional cash dividend of 0.44 euros per share, and a new share buyback of 25 million euros . FY operating result 126.9 million euros versus 108.6 million euros . In the food business segment, we expect a better sales growth performance in 2017 than the year before . Biochemicals business segment is also expected to show an improved sales growth performance in 2017 compared to 2016 . For biobased ingredients, we expect full-year sales growth to be within the multi-year average guidance range of 2-4 pct . Financial guidance 2015-2018: Corbion continues to target a net debt/EBITDA ratio of 1.5x, over the investment cycle . Overall capital expenditure in 2017 is expected to be between 60-70 million euros . EBITDA margin in biobased ingredients is expected to remain firmly above the 18 pct target level .We expect some EBITDA margin pressure and our EBITDA excluding one-off items for 2017 to be slightly below that of 2016.  Full Article

BRIEF-Corbion approved as highest bidder in sale of microalgae specialist Terravia

* Reg-Corbion approved as highest bidder in sale of innovative microalgae specialist Terravia